- Report
- February 2021
- 360 Pages
United States
From €2311EUR$2,400USD£1,988GBP
Invirase is a brand of antiretroviral drug used to treat HIV/AIDS. It is a protease inhibitor, which works by blocking the action of the HIV protease enzyme, preventing the virus from replicating. Invirase is used in combination with other antiretroviral drugs to treat HIV infection. It is available in tablet and oral suspension form.
Invirase is one of several antiretroviral drugs used to treat HIV/AIDS. Other drugs in this class include Atripla, Combivir, and Truvada. These drugs are used in combination with other antiretroviral drugs to treat HIV infection.
The Invirase market is highly competitive, with several companies offering similar products. Companies in the market include Roche, Gilead Sciences, Merck, and Bristol-Myers Squibb. These companies are all major players in the HIV/AIDS drug market, and they offer a range of products to treat HIV infection. Show Less Read more